CD44 and cancer: An in vitro cancer-targeting efficiency of synthesized core-shell nanoparticles was tested with both CD44 high expressing (MDA-MB 231 cells) and CD44 low expressing cells (NIH3T3 cells) using confocal laser scanning microscopy.